Regorafenib

CAS 755037-03-7

Em Estoque

Regorafenib

Cat. No. STUB-API-REGORAFENIBCAS 755037-03-7Em Estoque

Dados Técnicos

Cat. No.STUB-API-REGORAFENIB

CAS755037-03-7

Fórmula Mol.C₂₁H₁₅ClF₄N₄O₃

Peso Mol.482.821 g/mol

IUPAC4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide

SMILESCNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F

InChIInChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)

Chave InChIFNHKPVJBJVTLMP-UHFFFAOYSA-N

Pureza—

Descrição

Visão geral

Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase. Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition

A Anant Labs fabrica e fornece impurezas de Regorafenib de alta qualidade para o mercado global. Nossas impurezas EP de Regorafenib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Sinônimos

Regorafenib755037-03-7BAY 73-4506StivargaRegorafenibumBAY73-4506BAY-73-4506REGORAFENIB ANHYDROUS4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide24T2A1DOYB

Buscar APIs A–Z